Joël Mossong

13.1k total citations · 3 hit papers
84 papers, 4.8k citations indexed

About

Joël Mossong is a scholar working on Infectious Diseases, Epidemiology and Modeling and Simulation. According to data from OpenAlex, Joël Mossong has authored 84 papers receiving a total of 4.8k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Infectious Diseases, 39 papers in Epidemiology and 16 papers in Modeling and Simulation. Recurrent topics in Joël Mossong's work include COVID-19 epidemiological studies (16 papers), Viral gastroenteritis research and epidemiology (13 papers) and SARS-CoV-2 and COVID-19 Research (12 papers). Joël Mossong is often cited by papers focused on COVID-19 epidemiological studies (16 papers), Viral gastroenteritis research and epidemiology (13 papers) and SARS-CoV-2 and COVID-19 Research (12 papers). Joël Mossong collaborates with scholars based in Luxembourg, Belgium and United Kingdom. Joël Mossong's co-authors include W. John Edmunds, Niel Hens, Philippe Beutels, Jacco Wallinga, Marco Massari, Małgorzata Sadkowska-Todys, Magdalena Rosińska, Rafael Mikolajczyk, Mark Jit and Gianpaolo Scalia Tomba and has published in prestigious journals such as The Lancet, PLoS ONE and Applied and Environmental Microbiology.

In The Last Decade

Joël Mossong

81 papers receiving 4.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Social Contacts and Mixing Patterns Relevant to the Spread of Infectious Diseases

2008 1.9k citations Joël Mossong, Niel Hens et al. profile →
Life Expectancies of South African Adults Starting Antiretroviral Treatment: Collaborative Analysis of Cohort Studies

2013 312 citations Joël Mossong et al. profile →
Impact of nirsevimab prophylaxis on paediatric respiratory syncytial virus (RSV)-related hospitalisations during the initial 2023/24 season in Luxembourg

2024 81 citations Dritan Bejko, Anne Vergison et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Joël Mossong Luxembourg	31	2.1k	1.9k	1.7k	561	474	84	4.8k
Stefania Salmaso Italy	26	3.2k 1.5×	1.5k 0.8×	1.2k 0.7×	748 1.3×	283 0.6×	67	5.3k
Matthew Biggerstaff United States	30	1.6k 0.8×	1.6k 0.8×	1.4k 0.9×	340 0.6×	188 0.4×	81	4.0k
Virginia E. Pitzer United States	38	1.3k 0.6×	1.1k 0.6×	2.7k 1.6×	354 0.6×	739 1.6×	124	5.0k
Gérard Krause Germany	42	3.7k 1.7×	592 0.3×	1.9k 1.2×	586 1.0×	433 0.9×	225	7.4k
Peter Horby United Kingdom	40	2.5k 1.2×	826 0.4×	2.6k 1.5×	226 0.4×	378 0.8×	184	6.3k
Daniel M. Weinberger United States	38	3.6k 1.7×	582 0.3×	1.7k 1.0×	388 0.7×	202 0.4×	141	6.4k
Abdullah M. Assiri Saudi Arabia	41	1.3k 0.6×	1.5k 0.8×	4.6k 2.8×	398 0.7×	168 0.4×	156	7.5k
Johan Giesecke Sweden	34	1.2k 0.6×	440 0.2×	1.8k 1.1×	461 0.8×	510 1.1×	144	4.8k
Rebecca F. Grais United States	43	2.0k 0.9×	1.7k 0.9×	2.4k 1.5×	943 1.7×	157 0.3×	193	6.9k
James S. Koopman United States	37	2.0k 1.0×	978 0.5×	2.0k 1.2×	240 0.4×	140 0.3×	92	5.0k

Countries citing papers authored by Joël Mossong

Since Specialization

Citations

This map shows the geographic impact of Joël Mossong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joël Mossong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joël Mossong more than expected).

Fields of papers citing papers by Joël Mossong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joël Mossong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joël Mossong. The network helps show where Joël Mossong may publish in the future.

Co-authorship network of co-authors of Joël Mossong

This figure shows the co-authorship network connecting the top 25 collaborators of Joël Mossong. A scholar is included among the top collaborators of Joël Mossong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joël Mossong. Joël Mossong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bejko, Dritan, et al.. (2024). High vaccine effectiveness against severe COVID-19 outcomes and population preventable fraction during the Omicron era in Luxembourg: A nationwide retrospective risk factor analysis. Vaccine. 42(22). 126011–126011. 2 indexed citations

Pires‐Afonso, Yolanda, et al.. (2023). A Molecular and Epidemiological Investigation of a Large SARS-CoV-2 Outbreak in a Long-Term Care Facility in Luxembourg, 2021. Geriatrics. 8(1). 19–19. 1 indexed citations

Wilmes, Paul, Jacques Zimmer, Laurent Mombaerts, et al.. (2021). SARS-CoV-2 transmission risk from asymptomatic carriers: Results from a mass screening programme in Luxembourg. The Lancet Regional Health - Europe. 4. 100056–100056. 57 indexed citations

Wilmes, Paul, et al.. (2021). Generalisation of COVID-19 incidences provides a biased view of the actual epidemiological situation. The Lancet Regional Health - Europe. 5. 100116–100116.

Mossong, Joël, Laurent Mombaerts, Jessica Pastore, et al.. (2021). SARS-CoV-2 transmission in educational settings during an early summer epidemic wave in Luxembourg, 2020. BMC Infectious Diseases. 21(1). 417–417. 14 indexed citations

Llarena, Ann‐Katrin, Malte Herold, Joël Mossong, et al.. (2021). Investigating Major Recurring Campylobacter jejuni Lineages in Luxembourg Using Four Core or Whole Genome Sequencing Typing Schemes. Frontiers in Cellular and Infection Microbiology. 10. 608020–608020. 18 indexed citations

Fagherazzi, Guy, Aurélie Fischer, Fay Betsou, et al.. (2020). Protocol for a prospective, longitudinal cohort of people with COVID-19 and their household members to study factors associated with disease severity: the Predi-COVID study. BMJ Open. 10(11). e041834–e041834. 18 indexed citations

Latsuzbaia, Ardashel, et al.. (2019). Effectiveness of bivalent and quadrivalent human papillomavirus vaccination in Luxembourg. Cancer Epidemiology. 63. 101593–101593. 24 indexed citations

Latsuzbaia, Ardashel, Marc Arbyn, Steven Weyers, & Joël Mossong. (2018). Human papillomavirus vaccination coverage in Luxembourg – Implications of lowering and restricting target age groups. Vaccine. 36(18). 2411–2416. 5 indexed citations

10.

Mossong, Joël, Lapo Mughini‐Gras, Christian Penny, et al.. (2016). Human Campylobacteriosis in Luxembourg, 2010–2013: A Case-Control Study Combined with Multilocus Sequence Typing for Source Attribution and Risk Factor Analysis. Scientific Reports. 6(1). 20939–20939. 62 indexed citations

11.

Merabishvili, Maia, Daniël De Vos, Gilbert Verbeken, et al.. (2012). Selection and Characterization of a Candidate Therapeutic Bacteriophage That Lyses the Escherichia coli O104:H4 Strain from the 2011 Outbreak in Germany. PLoS ONE. 7(12). e52709–e52709. 42 indexed citations

12.

Mossong, Joël, et al.. (2012). Hypertension and Obesity in Adults Living in a High HIV Prevalence Rural Area in South Africa. PLoS ONE. 7(10). e47761–e47761. 113 indexed citations

13.

Flasche, Stefan, Niel Hens, Pierre‐Yves Boëlle, et al.. (2011). Different transmission patterns in the early stages of the influenza A(H1N1)v pandemic: A comparative analysis of 12 European countries. Epidemics. 3(2). 125–133. 35 indexed citations

14.

Kremer, Jacques R., Jérémie Langlet, Sylvain Skraber, et al.. (2010). Genetic diversity of noroviruses from outbreaks, sporadic cases and wastewater in Luxembourg 2008–2009. Clinical Microbiology and Infection. 17(8). 1173–1176. 27 indexed citations

15.

Mossong, Joël, Matthias Opp, Nancy Gerloff, et al.. (2009). Emergence of oseltamivir-resistant influenza A H1N1 virus during the 2007–2008 winter season in Luxembourg: Clinical characteristics and epidemiology. Antiviral Research. 84(1). 91–94. 4 indexed citations

16.

Hens, Niel, Girma Minalu Ayele, Nele Goeyvaerts, et al.. (2009). Estimating the impact of school closure on social mixing behaviour and the transmission of close contact infections in eight European countries. BMC Infectious Diseases. 9(1). 187–187. 168 indexed citations

17.

Strock, Paul, et al.. (2008). Access to Treatment of Hepatitis C in Prison Inmates. Digestive Diseases and Sciences. 54(6). 1325–1330. 21 indexed citations

18.

Mossong, Joël, Niel Hens, Irja Davidkin, et al.. (2007). Parvovirus B19 infection in five European countries: seroepidemiology, force of infection and maternal risk of infection. Epidemiology and Infection. 136(8). 1059–1068. 93 indexed citations

19.

Mossong, Joël, et al.. (2004). Seroprevalence of measles, mumps and rubella antibodies in Luxembourg: results from a national cross-sectional study. Epidemiology and Infection. 132(1). 11–18. 44 indexed citations

20.

Mossong, Joël & Claude P. Muller. (2000). Estimation of the basic reproduction number of measles during an outbreak in a partially vaccinated population. Epidemiology and Infection. 124(2). 273–278. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact